Legal & General Group Adds $4M in Alcon Inc. ($ALC)

Key Points

  • Legal & General Group changed its Alcon Inc. ($ALC) stake by 1.4% last quarter, boosting to 3,950,897 shares worth $262.77 million.
  • Wall Street's consensus rating on $ALC is Buy and an average price target of $87.92.
  • $ALC last traded around $66.51.

Legal & General Group increased its position in Alcon Inc. ($ALC) by 1.4% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,950,897 shares of Alcon Inc. after buying 53,234 shares during the quarter. Legal & General Group's holdings in Alcon Inc. were worth $262.77 million as of its most recent filing.

Alcon Inc. ($ALC) Stock

Last price$66.51
Market cap$32.60B
P/E ratio40.03
Forward P/E16.84
PEG ratio1.50
Beta0.70
52-week low$61.84
52-week high$92.55
50-day MA$70.72
200-day MA$76.34
Current ratio2.20
Quick ratio1.22
Debt-to-equity0.24

Alcon Inc. Earnings

EPS (ttm)$1.67
Revenue (ttm)$10.63B
Revenue growth9.4%
Net margin7.7%
Return on equity3.7%
Next earningsMay 5, 2026

Alcon Inc. Dividend

Annual dividend$0.36
Dividend yield54.00%
Payout ratio20.4%
Ex-dividend dateMay 6, 2026

Analysts Set New Price Targets

ConsensusBuy
Average target$87.92
High target$107.40
Low target$66.00
Analysts covering15

About Alcon Inc.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

ExchangeNYSE
SectorHealthcare
IndustryMedical Instruments & Supplies
HeadquartersGeneva, Switzerland
CEOMr. David J. Endicott
Employees25,000

See Also

This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.